The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback